

SMARCA-BD ligand 1 for Protac dihydrochloride
CAS No. 2369053-68-7
SMARCA-BD ligand 1 for Protac dihydrochloride( —— )
Catalog No. M33234 CAS No. 2369053-68-7
SMARCA-BD ligand 1 for Protac dihydrochloride binds to the BAF ATPase subunit SMARCA2 and is used for degrading SMARCA2 based on PROTAC.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 93 | Get Quote |
![]() ![]() |
5MG | 140 | Get Quote |
![]() ![]() |
10MG | 227 | Get Quote |
![]() ![]() |
25MG | 364 | Get Quote |
![]() ![]() |
50MG | 523 | Get Quote |
![]() ![]() |
100MG | 700 | Get Quote |
![]() ![]() |
500MG | 1413 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSMARCA-BD ligand 1 for Protac dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionSMARCA-BD ligand 1 for Protac dihydrochloride binds to the BAF ATPase subunit SMARCA2 and is used for degrading SMARCA2 based on PROTAC.
-
DescriptionSMARCA-BD ligand 1 for Protac dihydrochloride is a compound that binds to the BAF ATPase subunits SMARCA2, and used for degrading SMARCA2, based on PROTAC.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2369053-68-7
-
Formula Weight344.24
-
Molecular FormulaC14H19Cl2N5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2.7 mg/mL (7.84 mM; Ultrasonic (<60°C)
-
SMILESCl.Cl.Nc1nnc(cc1N1CCNCC1)-c1ccccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Farnaby W, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019 Jul;15(7):672-680.?
molnova catalog



related products
-
3-methyl-1,2-dihydro...
3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
-
SMARCA-BD ligand 1 f...
SMARCA-BD ligand 1 for Protac is a compound that binds to SMARCA2, the BAF ATPase subunit, utilizing Protac technology to degrade SMARCA2.
-
BRD4?Inhibitor-27
BRD4?Inhibitor-27 is a potent BRD4 inhibitor that inhibits BRD4 BD1 and BRD4 BD2 with IC50s of 9.6 and 11.3 μM, respectively.BRD4?Inhibitor-27 has anticancer activity and can be used for breast cancer research.